Orion Oyj header image

Orion Oyj

OFK0

Equity

ISIN null / Valor 11196876

Deutsche Boerse AG (2025-01-15)
EUR 45.82+3.67%

Orion Oyj
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Orion Oyj is a Finnish pharmaceutical company that places a strong emphasis on partnerships and networking across its value chain. The company collaborates with other organizations in various areas such as research and development, manufacturing, and marketing of pharmaceutical products on a global scale. With a focus on innovation and international expansion, Orion Oyj aims to deliver high-quality healthcare solutions to patients worldwide.

Summarized from source with an LLMView SourceSector:

Latest Results (24.12.2024):

Net Sales Growth

In the first nine months of 2024, Orion Oyj reported a significant increase in net sales, reaching EUR 1,108.0 million, compared to EUR 868.5 million in the same period of 2023. This represents a growth of 27.6%, driven by milestone payments and strong performance of key products like Nubeqa® and Easyhaler®.

Operating Profit Surge

Orion Oyj's operating profit for January to September 2024 saw a substantial rise, amounting to EUR 323.8 million, up from EUR 182.0 million in the previous year. This 77.9% increase was largely attributed to milestone payments and improved sales performance across various business divisions.

Earnings Per Share

The basic earnings per share for Orion Oyj in the first three quarters of 2024 were EUR 1.83, a significant increase from EUR 1.01 in the same period of 2023. This reflects the company's enhanced profitability and successful financial management during the period.

Cash Flow Improvement

Orion Oyj reported a notable improvement in cash flow from operating activities per share, which rose to EUR 1.46 in the first nine months of 2024, compared to EUR 0.50 in the same period of the previous year. This increase underscores the company's strong operational performance and effective cash management strategies.

Upgraded Financial Outlook

During the reporting period, Orion Oyj upgraded its financial outlook for 2024. The company now estimates net sales to be between EUR 1,470 million and EUR 1,510 million, with operating profit expected to range from EUR 370 million to EUR 400 million. This revision reflects the company's confidence in its ongoing growth and strategic initiatives.

Summarized from source with an LLMView Source

Key figures

125%1Y
%3Y
%5Y

Performance

183%1Y
60.9%3Y
60.9%5Y

Volatility

Market cap

5941 M

Market cap (USD)

Daily traded volume (Shares)

413,753

Daily traded volume (Shares)

1 day high/low

20.8 / 20.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00